InvestorsHub Logo
Followers 6
Posts 1087
Boards Moderated 0
Alias Born 07/18/2006

Re: Maciste post# 8309

Tuesday, 04/30/2019 12:42:02 PM

Tuesday, April 30, 2019 12:42:02 PM

Post# of 17441
"We're in discussions with a number of companies"- Neil Solomons during 1st question during Q&A. The "Q" was re Restasis annual sales (I think Neil said, $1B then around $1.5B).

Neil's response re multiple company discussions re VOS was a response to the questioner asking about talking with Allergan.

Also interesting was Neil's response to a question why the stock tanked after the VOS trial results: Neil said something like "I can't explain why the stock reacted as it did as the drug was extremely successful. Traders perhaps reacted to the headline 'Missed Primary Endpoint'"

Neil also said Aurinia is currently burning approximately $20M per quarter.

Excellent presentation- to hear the replay go to:

https://ir.auriniapharma.com/ir-calendar/detail/1136/2019-bloom-burton-co-healthcare-investor-conference

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News